SOLNATIDE, the therapeutic molecule solnatide developed by APEPTICO for the treatment of various forms of life-threatening...
Read MoreNews
28
Apr
Apeptico press release
SOLNATIDE has been approved for the treatment of COVID-19 patients suffering from pulmonary oedema and acute respiratory...
Read More
The spread of Coronavirus continues both in Italy and globally.
For this reason, in order to protect the...
Read MoreEvents
Meet one of our delegates at one of the conferences below and find out how OPIS can assist you in your clinical drug development programmes.
SCOPE SUMMIT 2020 is focused on advances and innovative solutions in all sectors of clinical trial planning, management...
Read More
BIO CEO & Investors Conference, New York, 10-11 February. We're waiting for you at one of the largest independent...
Read More
See you in Munich on the 5th and the 6th of February at the Outsourcing in Clinical Trials Medical Devices Europe...
Read More
22
Jan
Toulouse Onco Week
OPIS's team will participate at the Toulouse Onco Week: an opportunity to bring together the different actors...
Read More
Important topics will be discussed at Cell Therapy Manufacturing & Gene Therapy Congress, Amsterdam, 3 - 6 December...
Read More
The paradigm of treating disease has shifted. Today, we are exploring options where personalized medicines are promising...
Read More
1
Next